Dr. David Berz, MD, PhD, MPH is triple board certified in Oncology, Hematology, and Internal Medicine. He specializes in lung cancer as well as other malignancies and is a leading expert in this field, having multiple key publications in this area. Dr. Berz earned his medical degree from Humboldt University of Berlin and his Masters of Public Health from Brown University and has practiced medicine for over 20 years. He commits himself to supporting a diverse population of patients, as he is fluent in multiple languages such as German, Spanish, and Russian, and has experience practicing medicine globally. He additionally leads the way in remote monitoring technology, providing patients with around the clock support and early symptom detection. As Principal Investigator, Dr. Berz continues to provide his patients with cutting edge quality care through the latest research and clinical trials, conducted through Valkyrie Clinical Trials. Outside of Valkyrie, Dr. Berz enjoys traveling, soccer, and hiking.